IP Library Patent Application 14703337
Patent Application
App. No. 14/703,337

ANTIMICROBIAL FERULIC ACID DERIVATIVES AND USES THEREOF

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/703,337
Abstract

Antimicrobial diferulates, compositions containing same, and uses of same for inhibiting growth of microorganisms. The antimicrobial diferulates can be used alone or in combination with other antimicrobial agents to inhibit growth of microorganisms such as fungi, oomycetes, and other microorganisms having a glucan-containing cell wall. The antimicrobial diferulates can be included in pharmaceutical compositions for treatment of animals or included in agricultural compositions for treatment of plants, crops, and soils.

Claims (32)

1 . An antimicrobial composition comprising an antimicrobial-effective amount of a substantially purified compound selected from the group consisting of a compound of Formula I, a compound of Formula II, and combinations thereof, in combination with an inert carrier, wherein:

the compound of Formula I is selected from the group consisting of:

wherein R 1 -R 5 are each independently selected from the group consisting of hydrogen, C1-C6 linear, branched, or cyclic alkyl, and C6 aryl; and a salt thereof; and

the compound of Formula II is selected from the group consisting of:

wherein R 6 -R 10 are each independently selected from the group consisting of hydrogen, C1-C6 linear, branched, or cyclic alkyl, and C6 aryl; and a salt thereof.

2 . The composition of claim 1 wherein the substantially purified compound comprises the compound of Formula I and the compound of Formula II.

3 . The composition of claim 1 wherein the compound of Formula I is selected from the group consisting of:

and a salt thereof.

4 . The composition of claim 1 wherein the compound of Formula II is selected from the group consisting of:

and a salt thereof.

5 . The composition of claim 1 wherein the composition is substantially devoid of one or more diferulate compounds selected from the group consisting of 5-5 diferulate, 8-5-O diferulate, 8-8-C diferulate, 8-8-THF diferulate, 4-O-5 diferulate, 8-O-4 diferulate, and 8-8-O diferulate.

6 . The composition of claim 1 wherein the composition comprises from about 0.01% to about 95% by mass of the substantially purified compound.

7 . The composition of claim 1 wherein the composition comprises at least 5% water by mass.

8 . The composition of claim 1 wherein the inert carrier comprises a solid carrier.

9 . The composition of claim 1 wherein the inert carrier comprises a semi-solid carrier.

10 . The composition of claim 1 wherein the inert carrier comprises a liquid carrier including at least 5% water by mass.

11 . The composition of claim 1 further comprising an additional antimicrobial compound.

12 . The composition of claim 11 wherein the additional antimicrobial compound comprises an antifungal compound.

13 . The composition of claim 12 wherein the antifungal compound comprises a cell-wall targeting agent.

14 . A method of inhibiting growth of a microorganism comprising contacting the microorganism with a composition as recited in claim 1 .

15 . The method of claim 14 wherein the microorganism comprises a glucan-containing cell wall.

16 . The method of claim 14 wherein the microorganism is selected from the group consisting of a fungus and an oomycete.

17 . A method of inhibiting microbial infection in a host comprising administering to the host a composition as recited in claim 1 .

18 . The method of claim 17 wherein the administering inhibits growth of a microorganism comprising a glucan-containing cell wall.

19 . The method of claim 17 wherein the administering inhibits growth of a microorganism selected from the group consisting of a fungus and an oomycete.

20 . The method of claim 17 wherein the host is an animal.

21 . The method of claim 17 wherein the host is a plant.

22 . A method of inhibiting growth of a microorganism comprising contacting the microorganism with an effective amount of a substantially purified compound selected from the group consisting of a compound of Formula I, a compound of Formula II, and combinations thereof, wherein:

the compound of Formula I is selected from the group consisting of:

wherein R 1 -R 5 are each independently selected from the group consisting of hydrogen, C1-C6 linear, branched, or cyclic alkyl, and C6 aryl; and a salt thereof; and

the compound of Formula II is selected from the group consisting of:

wherein R 6 -R 10 are each independently selected from the group consisting of hydrogen, C1-C6 linear, branched, or cyclic alkyl, and C6 aryl; and a salt thereof.

Assignments (3)
CONFIRMATORY LICENSE Recorded Oct 22, 2021
From: UNIVERSITY OF WISCONSIN-MADISON
To: UNITED STATES DEPARTMENT OF ENERGY
Reel/Frame 057892/0392 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2015
From: ROBERT H. HOLBER, CHAPTER 7 TRUSTEE FOR INTHEPLAY, INC. MAXX HOLDINGS, INC., TS&E, INC. AND JAMES A. AMAN (COLLECTIVELY, THE "PARTIES")
To: MAXX HOLDINGS, INC.
Reel/Frame 035905/0530 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 4, 2015
From: KABBAGE, MEHDI; LANDICK, ROBERT; RALPH, JOHN; PIOTROWSKI, JEFF; LU, FACHUANG
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 035784/0507 →